KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) FCF Margin: 2010-2015

Historic FCF Margin for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -116.52%.

  • Biocryst Pharmaceuticals' FCF Margin rose 15013.00% to -116.52% in Q3 2015 from the same period last year, while for Sep 2015 it was -29.57%, marking a year-over-year increase of 12645.00%. This contributed to the annual value of -284.08% for FY2014, which is 13082.00% down from last year.
  • According to the latest figures from Q3 2015, Biocryst Pharmaceuticals' FCF Margin is -116.52%, which was down 243.12% from 81.41% recorded in Q2 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' FCF Margin peaked at 1,061.81% during Q1 2012, and registered a low of -484.45% during Q2 2014.
  • Its 3-year average for FCF Margin is -218.79%, with a median of -259.28% in 2014.
  • In the last 5 years, Biocryst Pharmaceuticals' FCF Margin skyrocketed by 61,446bps in 2012 and then slumped by 137,689bps in 2013.
  • Over the past 5 years, Biocryst Pharmaceuticals' FCF Margin (Quarterly) stood at -76.28% in 2011, then skyrocketed by 61,446bps to 550.17% in 2012, then plummeted by 90,279bps to -42.77% in 2013, then crashed by 21,348bps to -256.24% in 2014, then skyrocketed by 15,013bps to -116.52% in 2015.
  • Its FCF Margin stands at -116.52% for Q3 2015, versus 81.41% for Q2 2015 and -62.86% for Q1 2015.